Plans IND filings for two injectable products by the end of 1990: thyroid stimulating hormone (TSH) and Ananain. TSH is intended as an in vivo diagnostic as well as a therapeutic for thyroid cancer metastases. The drug would allow patients after thyroid removal to continue hormonal replacement therapy while undergoing full body radiation scan to treat metastases. The pineapple stem extract, Ananain, is being developed as a debriding agent to remove dead tissue from wounds such as skin ulcers and burns.
You may also be interested in...
Teva has launched its generic version of NuvaRing in the US, adding a second rival generic to the market that already includes Amneal, as well as an authorized generic version from Prasco.
Deals announced by Sanofi and Novartis at this year’s virtual J.P. Morgan Healthcare Conference and a smattering of full-year revenue preannouncements did not mark a bumper start to the year.
The US HHS was responsible for the most major regulations over the last few years of any agency, an OMB report shows.